Holden Comprehensive Cancer Center Research Executive Committee

The Research Executive Committee is responsible for implementing the research mission of the cancer center and reviews the performance of shared research resources, discusses progress within the research programs, identifies opportunities to enhance collaborations. The committee is composed of Holden leadership and program co-leaders.

Chair

Michael D. Henry

Michael D. Henry, PhD

  • Deputy Director for Research
  • Professor

Members

Natoshia M. Askelson

Natoshia M. Askelson, MPH, PhD

  • Director for Community Outreach and Engagement
  • Associate Professor
Gail A. Bishop

Gail A. Bishop, PhD

  • Associate Director of Basic Research for Holden Comprehensive Cancer Center
  • Professor
Mark E. Burkard

Mark E. Burkard, MD, PhD

  • C.E. Block Chair of Cancer Research
  • Director, Holden Comprehensive Cancer Center
  • Professor
Mary Charlton

Mary Charlton, PhD, BSN

  • Co-leader, Cancer Epidemiology and Population Science (CEPS)
  • Professor
Elizabeth Chrischilles

Elizabeth Chrischilles, PhD

  • Associate Director for Population Science
  • Department of Epidemiology Chair
  • Pomerantz Chair in Public Health
  • Health Effectiveness Research Center Director
  • Professor
Tina R. Devery

Tina R. Devery, MHA

  • HCCC Associate Director for Administration
Rebecca D. Dodd

Rebecca D. Dodd, PhD

  • Co-leader, Cancer Genes and Pathways (CGP) Program
  • Associate Professor
Adam J. Dupuy

Adam J. Dupuy, PhD

  • Associate Director of Shared Resources for Holden Comprehensive Cancer Center
  • Associate Professor
Muhammad Furqan

Muhammad Furqan, MD

  • Interim Associate Director of Clinical Research
  • Medical Director of Clinical Research Services, Holden Comprehensive Cancer Center
  • Clinical Professor
David J. Gordon

David J. Gordon, MD, PhD

  • Associate Professor
Jessica S. Gorzelitz

Jessica S. Gorzelitz, PhD

  • Emerging Leaders Council (ELC) Chair, Holden Comprehensive Cancer Center
  • Assistant Professor, Department of Health and Human Physiology
  • Assistant Program Leader of the Cancer Epidemiology and Population Science (CEPS) Program
Jon C. Houtman

Jon C. Houtman, PhD

  • Associate Director of Career Enhancement at Holden Comprehensive Cancer Center
  • Professor
Yusuf Menda

Yusuf Menda, MD

  • Co-leader, Free Radical Metabolism and Imaging (FRMI) Program
  • Professor
Dawn E. Quelle

Dawn E. Quelle, PhD

  • Co-leader, Cancer Genes and Pathways (CGP) Program
  • Professor
Sarah P. Short

Sarah P. Short, PhD

  • Emerging Leaders Council (ELC) Vice-Chair, Holden Comprehensive Cancer Center
  • Assistant Professor
Andrean L. Simons-Burnett

Andrean L. Simons-Burnett, PhD

  • Associate Professor
Douglas R. Spitz, Jr.

Douglas R. Spitz, Jr., PhD

  • Co-leader, Free Radical Metabolism and Imaging (FRMI) Program
  • Professor
Erin E. Talbert

Erin E. Talbert, PhD

  • Assistant Professor, Department of Health and Human Physiology
  • Assistant Program Leader of the Cancer Genes and Pathways (CGP) Program
Kristina W. Thiel

Kristina W. Thiel, PhD

  • Assistant Professor, Department of Obstetrics and Gynecology
  • Assistant Program Leader of the Experimental Therapeutics (ET) Program
Mark W. Vander Weg

Mark W. Vander Weg, PhD

  • Co-leader, Cancer Epidemiology and Population Science (CEPS)
  • Head of Community and Behavioral Health
  • Professor
George J. Weiner

George J. Weiner, MD

  • Director Emeritus for Holden Comprehensive Cancer Center
  • Professor
Michael K. Wendt

Michael K. Wendt, PhD

  • Leader, Experimental Therapeutics (ET) Program
  • Associate Professor